UROLITHIASIS is a common condition with a prevalence of about 9% in the general population. 1, 2 Although it is generally considered an unpleasant but relatively benign condition, urolithiasis can impair kidney function as a consequence of the renal stone per se (obstruction, infection), parenchymal damage induced by the primary condition leading to stone formation (some monogenic disorders, nephrocalcinosis, secondary hyperoxaluria etc) or urological treatments for the condition. 3 The present literature review was conducted to ascertain the entity of the risk of kidney impairment in stone formers, whether specific conditions are associated with this risk (eg demographics, type of stone etc) and the role of urological surgery. We specifically looked for evidence addressing specific questions. 1) Is there a risk of chronic kidney disease and end stage renal disease associated with nephrolithiasis? 2) Which stone formers are at high risk for CKD/ESRD? 3) Do urological treatments for stones cause irreversible kidney damage, thereby increasing the risk of CKD/ESRD? 4) Which factors are associated with a higher risk of CKD/ESRD after urological treatments for stones? 5) What is the risk of nephrectomy in urolithiasis?
METHODS

Search Strategy
The terms used to search specialized registries (PubMed, Embase) for the purpose of this analysis are listed in the supplementary Appendix (http://jurology.com/). The search covered the period from January 1965 to July 2016 and was limited to the English language. A few articles were also retrieved from the reference lists of review articles and relevant studies. We considered randomized controlled trials as well as observational studies.
Data Extraction and Analysis
All identified publications were scrutinized for relevance to the study before inclusion, based initially on title and abstract, and then by reading the full texts. For all selected articles, data were extracted by 1 reviewer and checked by a second reviewer using a data extraction form that included patient characteristics, methodological quality, study characteristics, details of interventions and outcome measures. The GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system was used to ascertain the validity of the eligible studies and the strength of the evidence. The outcome measures considered were ESRD or CKD stages, 4 or predetermined levels of glomerular filtration rate or serum creatinine.
RESULTS
Risk of CKD/ESRD Associated with Nephrolithiasis
The literature available on this topic amounted to 399 papers, of which 17 were considered in the present review. Among these 17 only 5 cohort studies assessed the risk of incident CKD/ESRD in patients with urolithiasis and 2 cross-sectional studies estimated the probability of CKD associated with a history of renal stones.
In a prospective open cohort study using data from a primary care population of 1.5 million, 2 scores were developed to estimate the individual 5-year risk of moderate-severe CKD and ESRD. 5 Using both scores a history of renal stones was associated with a risk of CKD in women. The risk of GFR less than 45 ml per minute was 27% higher in female stone formers than in women with no history of stones.
In a registry cohort study 1 or more stone episodes were associated with a higher risk of ESRD (adjusted HR 2.16; 95% CI 1.79, 2.62), new onset CKD stage 3b-5 (HR 1.74; 95% CI 1.61, 1.88) and doubling serum creatinine levels (HR 1.94; 95% CI 1.56, 2.43). 6 The excess risk of adverse outcomes associated with 1 or more stone episodes was greater in women than in men, and in people less than 50 years old. However, the absolute rates of adverse renal outcomes associated with stones were modest. The unadjusted rate of ESRD was 2.48 per million person-days for individuals with a history of stones vs 0.52 per million person-days for the remainder of the population.
A registry study on residents of Olmsted County, Minnesota confirmed that stone formers were at higher risk for ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout and CKD (HR 2.09; 95% CI 1.45, 3.01). 7 Compared with controls, stone formers in whom ESRD developed were more likely to have a history of hydronephrosis (44% vs 4%), recurrent UTIs (26% vs 4%), acquired single kidney (15% vs 3%), neurogenic bladder (12% vs 1%) and ileal conduit (9% vs 0%), but not diabetes or hypertension. The risk of ESRD attributable to urolithiasis, ie new cases of ESRD secondary to urolithiasis and its complications or associated conditions, was estimated to be only 5.1% of all ESRD cases.
The Alberta and Olmsted County studies presented similar estimates of the risk of ESRD in stone formers among the general population, identifying an approximately twofold risk in the former vs the latter. In a population based retrospective study of 11,570 participants with incident urolithiasis and 127,464 without urolithiasis in The Health Improvement Network, the HR for CKD among the former vs the latter was 1.82 (95% CI 1.67, 1.98). 8 Among 10,678 participants in the Atherosclerosis Risk in Communities Study the adjusted risk of incident CKD was only 10% higher for those with a history of kidney stones and was not statistically significant. 9 However, the risk was significantly higher among those with plasma uric acid levels of 6 mg/dl or less (HR 1.34; 95% CI 1.05, 1.72). The use of diagnostic codes to define CKD could partially explain the overall null findings of this study.
Among participants in the NHANES III with a history of kidney stones and a body mass index of 27 kg/m 2 or greater, the probability of having a GFR less than 60 vs greater than 90 ml per minute was 87% higher than in overweight people who were not stone formers. 10 In the NHANES 2007-2010 database a history of kidney stones was associated with CKD, ie GFR less than 60 ml per minute (OR 1.76; 95% CI 1.13, 2.76) in women, but not in men, and with dialysis (OR 3.26; 95% CI 1.48, 7.16). 11 A community based study in Shanghai, China found nephrolithiasis more prevalent in patients with CKD than in those without CKD (supplementary table 1, reference 13).
A number of generally poor quality, often casecontrol and single center studies, also support the role of renal stones as a risk factor for CKD. In a case-control study on Egyptian hemodialysis cases a history of renal stones emerged as an independent risk factor for ESRD (supplementary table 1, reference 14). In another case-control study on patients newly diagnosed with CKD, the odds of CKD (based on kidney related ICD-9 discharge diagnoses) among those without hypertension were 3 times higher (95% CI 1.3, 6.8) for patients with vs without kidney stones after adjusting for all covariables. 12 The risk factors for CKD/ESRD in stone formers from studies on the general population are listed in Appendix 1.
None of these studies distinguished the risk of CKD by phenotype of the underlying disorder causing the stone. However, renal stones have a different risk of inducing CKD depending on their etiology and composition. This was demonstrated by Worcester et al, who analyzed creatinine clearance in more than 1,800 patients with urolithiasis. 13 The lowest creatinine clearance values (although still not severe enough to be classified as CKD stage 3 or greater) were seen in cystinuria, in uric acid and struvite stones, and in overt renal tubular acidosis and intestinal related nephrolithiasis. In a study on 40 patients with cystinuria only 30% had functionally unaffected kidneys with a normal GFR and bilaterally normal renography (supplementary table 1, reference 21). In a larger cohort of 95 patients with cystinuria Assimos et al found higher serum creatinine levels and a higher prevalence of nephrectomy than in calcium oxalate stone formers.
14 The high prevalence of CKD in cystinuria was confirmed in a recently published French study on 442 patients with cystinuria, of whom 26.7% had CKD (although only 5 patients had ESRD), and only 22.5% had an estimated GFR greater than 90 ml per minute. 15 In these studies on cystinuric stone formers a history of staghorn stones and of multiple open surgical procedures for stone removal constituted a relevant risk factor for CKD and nephrectomy.
In a cross-sectional study on more than 1,900 patients in whom stones were analyzed using infrared spectroscopy, patients with struvite and uric acid stones had a lower GFR than those with calcium oxalate and phosphate stones. 16 Among patients treated with bariatric surgery techniques, standard Roux-en-Y gastric bypass and malabsorptive procedures are both associated with an increased risk of stones, but only the latter increased the risk of CKD as well (adjusted HR 1.96). 17 In patients with primary hyperparathyroidism renal stones were not associated with stage 3 CKD (supplementary table 1, reference 6).
Urological Treatments and CKD Our database search on this topic retrieved 274 papers and of these papers 25 were included in this review. Shock wave lithotripsy and percutaneous nephrolithotomy have been shown to damage the renal parenchyma. The amount of tissue irreversibly injured during a single procedure is generally small, 18 so there is generally an unmeasurable decline in the function of an otherwise normal kidney. However, leaving a stone untreated can risk damaging the whole kidney.
There are numerous caveats to consider when analyzing the available literature on this topic. Baseline renal function is critically important when investigating renal dysfunction occurring after a treatment because the contribution of the small parenchymal loss depends on its relative contribution to overall renal function. A variety of available urological treatments may have been used in the same patient, alone or in various combinations, and some patients must be treated repeatedly for the same stone or for recurrent stones. Unfortunately only a few articles enable us to disentangle these complexities. Any hypertension developing after SWL described in the past is another aspect to consider because it may well be a sign of renal damage. 19 As a general observation the available evidence on the impact of various stone removal techniques on GFR is of poor quality, deriving essentially from a number of small observational, single center, retrospective studies. Many of them are flawed for the following reasons. 1) Renal function was only assessed in the very short term (less than 3 months). 2) Cases of obstructive uropathy and/or complex/staghorn stones were included in the sample. With these conditions it may be difficult to quantify the net impact of factors potentially affecting renal function in opposite directions, eg the damage caused by the surgical procedure or by the prior obstructive/inflammatory damage, and any improvement in renal function after the obstruction was removed.
3) The methods used to assess renal function were inadequate (ie estimated GFR in patients with 2 kidneys). For the specific question addressed here the most informative studies are those concerning patients with single kidneys or those assessing renal function separately in each kidney by means of nuclear scanning.
It is also important for studies on the risk of CKD after SWL to report the specific treatment given, ie the number of shocks delivered per session and the number of sessions, which are bound to have changed during the course of almost 30 years (the first study retrieved dated from 1988). When we considered only the SWL studies published since 1995 and concerning adult patients with single kidneys or whose renal function was assessed with a split nuclear scan, we retrieved 3 reports on a total of 309 kidneys. 20e22 No effect of SWL on GFR or blood pressure was observed after a followup of at least 12 months. Two retrospective studies on a total of 439 patients whose bilateral renal stones were treated simultaneously with SWL found no variation in serum creatinine levels during a 12-month followup. 23, 24 In a small prospective study hypertension developed in only 1 of 25 patients more than 8 months after SWL (supplementary table 2, reference 37). In 4 studies on 231 children the renal scans performed after a followup of more than 3 months revealed deterioration in renal function in only 1 kidney.
25e28 Few studies have examined the risk of hypertension after SWL in children and appear to rule out this possibility. 25, 29 As for URSL 1 study on single kidney cases compared URSL with SWL and found no differences in terms of subsequent renal function. 30 Multiple URSL procedures did not alter the long-term GFR in stone formers with stage 2 to 3 CKD (supplementary table 2, reference 59) and GFR did not change after URSL in 9 patients whose renal function was examined by renal scan (supplementary table 2, reference 58).
In a retrospective study the risk of CKD (serum creatinine higher than 1.4 mg/dl in males or 1.2 mg/dl in females) in 87 stone formers treated with PCNL was much the same after a 19-year followup as in historical, unmatched cohorts of patients with stones not treated surgically, or treated with SWL, giving the impression that PCNL is at least as safe as other procedures. 31 In 2 studies on a total of 243 patients PCNL caused some deterioration in renal function in 9% to 15% of cases. 32, 33 This finding was likely related to multiple punctures and previously impaired renal function. Similar data emerged from a retrospective study on children (supplementary table 2, reference 31).
In a cross-sectional study of 171 patients with severe idiopathic calcium nephrolithiasis, those with a GFR less than 80 ml per minute experienced more extensive stone surgery and complications than those whose GFR was greater than 80 ml per minute (supplementary table 2, reference 24). Similar findings recently emerged from the CROES PCNL study of a registry cohort of more than 5,600 patients who underwent PCNL. 34 Patients with stage 4-5 CKD were those with a history of PCNL, URSL or nephrostomy, and they had positive urine cultures consistent with a higher prevalence of staghorn stones. The risk of CKD was also associated with the number of stone removal procedures performed, with a lower stone-free rate in single kidney cases. 35 A retrospective study on stone formers treated with SWL identified a 20% increase in the risk of stage 3 CKD for every 1 mm increase in stone burden up to 20 mm. Oddly enough this association was not seen for greater stone burdens (supplementary table 2, reference 23).
In patients with bilateral obstructive urolithiasis treated with flexible ureteroscopy or PCNL, the risk of stage 5 CKD at 1 year of followup was predicted independently by a combination of reduced cortical thickness, proteinuria, positive urine culture and lower preoperative GFR (supplementary table 2, reference 47). Apart from urinary infection, the other conditions are signs of CKD existing before treatment, and are typically considered when estimating the risk of CKD progression. In a recent retrospective study on 2,238 patients with urolithiasis treated with at least 1 SWL or ureteroscopy procedure, neither SWL nor ureteroscopy was associated with incident CKD. 8 In conclusion, the number and complexity of urological treatments, staghorn stones, stone burden, and prior advanced CKD appear to be the most relevant risk factors for severe, chronic renal damage after urological treatment for stones.
Risk of Nephrectomy in Urolithiasis
We retrieved 2,118 papers from the databases queried on the risk of nephrectomy in patients with urolithiasis, and of these 13 were included in this review. In patients with renal stones nephrectomy may be due to complications of kidney stones or of urological treatments. Some studies do not distinguish between these scenarios. No one is certain how often nephrectomy is performed in patients with renal stones or the reasons for it.
Among 3,266 patients attending a large outpatient stone clinic 3.5% had lost a kidney and the prevalence of kidney loss did not vary over 3 decades (1970 to 2003) . 36 From 2002 to 2007 nephrectomy was performed in less than 1% of 3,170 children hospitalized for renal stones in the United States. 37 A study on the trend in treatments for upper urinary tract calculi in the U.S. demonstrated no significant change in the need for nephrectomy during 1999 to 2009. 38 The reasons for kidney loss in patients with renal stones include obstruction, stone burden and infection. 36 In a Chinese study conducted between 2001 and 2010 the risk factors for kidney loss and nephrectomy in patients with upper urinary tract stones were calculus larger than 10 mm, loss to followup and poor standards of living. 39 Only a few studies have investigated the risk of nephrectomy in specific nephrolithiasis phenotypes. Struvite and calcium phosphate stones are more prevalent among single kidney stone formers 36 and, as already mentioned, patients with cystinuria are at higher risk for nephrectomy than calcium oxalate stone formers (14.1% vs 2.9%).
14 However, according to the findings in a case population of 48 cystinuric stone formers, the risk of nephrectomy has decreased since 1990, apparently due to the use of minimally invasive urological procedures. 40 A few single institution studies have reported on the risk of nephrectomy as a complication of PCNL. In the 2 largest series, involving 1,039 and 568 kidneys treated with PCNL, only 1 patient in each series (0.1% and 0.2% of the sample, respectively) required urgent nephrectomy for severe bleeding. 41, 42 Other smaller studies revealed a prevalence of up to 1%. 43, 44 In a Japanese study on 2,129 patients with ureteral stones who underwent URSL between 1985 and 2006 there were only 2 in whom nephrectomy was performed for ureteral perforation. 45 Taken together, these studies demonstrate that currently used urological treatments of renal and ureteral stones are safe. Although the risk of nephrectomy is low globally and may be decreasing, apparently due to modern urological approaches to stone removal, some types of stones (cystine and struvite) still carry a risk of nephrectomy. Careful patient followup is crucial to the prevention of such a severe complication.
DISCUSSION
Renal stone formers have an approximately twofold higher risk of impaired renal function or need for renal replacement therapy than the general population. Female and overweight stone formers are at greater risk, together with those who frequently have UTIs or struvite stones. Patients with urinary malformations and diversions, malabsorptive bowel syndromes or monogenic disorders that cause stones are at particularly high risk for CKD/ESRD. For the rarer forms of kidney stones an estimate of the risk of CKD/ESRD is proposed in Appendix 2 on the grounds of personal experience, case reports, previously cited studies and small observational studies. 18 While it is difficult to separate the relative contribution of mechanical and metabolic factors affecting renal function, it can be hypothesized that some conditions such as cystinuria, renal tubular acidosis and intestinal related nephrolithiasis involve a higher risk of kidney damage. Although to our knowledge there are no studies of sufficiently good quality available on the effects of noninvasive or minimally invasive stone treatment on renal function, it would seem that whenever clinically relevant renal damage is observed, it is mainly due to primary conditions demanding repeated and/or complex surgeries. Early access to the best urological treatments seems to be indispensable in avoiding severe renal damage, nephrectomy and ESRD.
CONCLUSIONS
Although the effect size is modest, urolithiasis should be seen as a condition that may lead to CKD. Therefore, it is mandatory to assess renal stone formers in terms of the global risk of CKD/ESRD. We recommend that all guidelines on renal stone disease include an assessment of this risk.
APPENDIX 1
Risk factors for CKD/ESRD in stone formers from studies on the general population 
